INS and Insulin resistance: The mechanisms underlying the anti-diabetic and anti-hyperglycemic activity of COS include the protection of pancreatic β cells and the promotion of insulin secretion, the alleviation of insulin resistance, the inhibition of carbohydrate-hydrolyzing enzymes, the promotion of glucose uptake, and the improvement of gut microbiota dysbiosis (Figure 2).